Open access
Aug 2026
Assessment of Cancer-Related Cognitive Impairments Across Anti-Cancer Therapies in a Predominantly Breast Cancer Cohort.
Cancer survivors frequently experience cancer-related cognitive impairment (CRCI), but the contributions of different anti-cancer therapies remain unclear. Patients with breast or gynaecological cancer were recruited before any anti-cancer treatment. Cognitive function was assessed by objective and subjective measures...
Qiqi Lei, M. Schmidt, P. Zimmer et al.
· International Journal of Can... · 0 citations